Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta?
- PMID: 25962526
- DOI: 10.1002/pd.4611
Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta?
Abstract
Osteogenesis imperfecta (OI) is characterized by severe bone deformities, growth retardation and bones that break easily, often from little or no apparent cause. OI is a genetic disorder primarily with defective type I collagen with a wide spectrum of clinical expression. In the more severe cases, it can be diagnosed before birth. Transplantation of mesenchymal stem cells (MSC) has the potential to improve the bone structure and stability, growth and fracture healing. Prenatal and postnatal cell transplantation has been investigated in preclinical and clinical studies of OI and suggests that this procedure is safe and has positive effects. Cell transplantation resulted in improved linear growth, mobility and reduced fracture incidence. However, the effect is transient and for this reason re-transplantation may be needed. So far there is limited experience in this area, and proper studies are required to accurately determine if MSC transplantation is of clinical benefit in the treatment of OI. In this review, we summarize what is currently known in this field.
© 2015 John Wiley & Sons, Ltd.
Similar articles
-
Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta.Front Pharmacol. 2014 Oct 9;5:223. doi: 10.3389/fphar.2014.00223. eCollection 2014. Front Pharmacol. 2014. PMID: 25346689 Free PMC article.
-
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience.Stem Cells Transl Med. 2014 Feb;3(2):255-64. doi: 10.5966/sctm.2013-0090. Epub 2013 Dec 16. Stem Cells Transl Med. 2014. PMID: 24342908 Free PMC article. Clinical Trial.
-
Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta.Curr Osteoporos Rep. 2020 Aug;18(4):337-343. doi: 10.1007/s11914-020-00594-3. Curr Osteoporos Rep. 2020. PMID: 32710427 Free PMC article. Review.
-
Current Overview of Osteogenesis Imperfecta.Medicina (Kaunas). 2021 May 10;57(5):464. doi: 10.3390/medicina57050464. Medicina (Kaunas). 2021. PMID: 34068551 Free PMC article. Review.
-
In utero stem cell transplantation for radical treatment of osteogenesis imperfecta: perspectives and controversies.Am J Perinatol. 2014 Nov;31(10):829-36. doi: 10.1055/s-0033-1363501. Epub 2013 Dec 17. Am J Perinatol. 2014. PMID: 24347264 Review.
Cited by
-
Embryo and fetal gene editing: Technical challenges and progress toward clinical applications.Mol Ther Methods Clin Dev. 2024 Mar 4;32(2):101229. doi: 10.1016/j.omtm.2024.101229. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38533521 Free PMC article. Review.
-
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.ACS Pharmacol Transl Sci. 2024 Jan 2;7(1):72-96. doi: 10.1021/acsptsci.3c00324. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2024. PMID: 38230285 Review.
-
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches.Stem Cells Int. 2019 Jun 2;2019:1730978. doi: 10.1155/2019/1730978. eCollection 2019. Stem Cells Int. 2019. PMID: 31281368 Free PMC article. Review.
-
Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases.Paediatr Drugs. 2019 Apr;21(2):95-106. doi: 10.1007/s40272-019-00330-0. Paediatr Drugs. 2019. PMID: 30941653 Review.
-
Reverse total shoulder arthroplasty in a patient with osteogenesis imperfecta type I complicated by a proximal humeral enchondroma: a case report and review of the literature.JSES Open Access. 2017 May 22;1(2):119-123. doi: 10.1016/j.jses.2017.03.012. eCollection 2017 Jun. JSES Open Access. 2017. PMID: 30675552 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
